These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29291407)

  • 1. Urine volatile organic compounds as biomarkers for minimal change type nephrotic syndrome.
    Liu D; Zhao N; Wang M; Pi X; Feng Y; Wang Y; Tong H; Zhu L; Wang C; Li E
    Biochem Biophys Res Commun; 2018 Jan; 496(1):58-63. PubMed ID: 29291407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.
    Wang M; Xie R; Jia X; Liu R
    Med Princ Pract; 2017; 26(4):375-380. PubMed ID: 28633145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
    Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
    Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile Organic Metabolites Identify Patients with Mesangial Proliferative Glomerulonephritis, IgA Nephropathy and Normal Controls.
    Wang C; Feng Y; Wang M; Pi X; Tong H; Wang Y; Zhu L; Li E
    Sci Rep; 2015 Oct; 5():14744. PubMed ID: 26443483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls.
    Cozzolino R; De Magistris L; Saggese P; Stocchero M; Martignetti A; Di Stasio M; Malorni A; Marotta R; Boscaino F; Malorni L
    Anal Bioanal Chem; 2014 Jul; 406(19):4649-62. PubMed ID: 24828982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
    Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation and validation of a HS-SPME-GC-IT/MS method for analysis of carbonyl volatile compounds as biomarkers in human urine: Application in a pilot study to discriminate individuals with smoking habits.
    Calejo I; Moreira N; Araújo AM; Carvalho M; Bastos Mde L; de Pinho PG
    Talanta; 2016 Feb; 148():486-93. PubMed ID: 26653476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs).
    Zhang S; Raftery D
    Methods Mol Biol; 2014; 1198():265-72. PubMed ID: 25270935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome.
    Wang Y; Zheng C; Wang X; Zuo K; Liu Z
    Mol Med Rep; 2017 Nov; 16(5):6276-6284. PubMed ID: 28849145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for Potential Markers of Glomerulopathy in Urine by HS-SPME-GC×GC TOFMS.
    Ligor T; Zawadzka J; Strączyński G; González Paredes RM; Wenda-Piesik A; Ratiu IA; Muszytowski M
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33804943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
    Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
    J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
    Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
    PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal profiling of human urine VOCs and its potential role under the ruins of collapsed buildings.
    Mochalski P; Krapf K; Ager C; Wiesenhofer H; Agapiou A; Statheropoulos M; Fuchs D; Ellmerer E; Buszewski B; Amann A
    Toxicol Mech Methods; 2012 Sep; 22(7):502-11. PubMed ID: 22482743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary volatile metabolites of amygdala-kindled mice reveal novel biomarkers associated with temporal lobe epilepsy.
    Fujita A; Ota M; Kato K
    Sci Rep; 2019 Jul; 9(1):10586. PubMed ID: 31332211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of volatile organic compounds (VOCs) from colorectal cancer cell line LS174T.
    Liu M; Li Y; Wang G; Guo N; Liu D; Li D; Guo L; Zheng X; Yu K; Yu K; Wang C
    Anal Biochem; 2019 Sep; 581():113340. PubMed ID: 31226253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose.
    Esfahani S; Wicaksono A; Mozdiak E; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2018 Dec; 8(4):. PubMed ID: 30513787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression.
    Wu HHL; Possell M; Nguyen LT; Peng W; Pollock CA; Saad S
    BMC Nephrol; 2024 Oct; 25(1):352. PubMed ID: 39407183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
    Tanaka M; Furuhashi M; Moniwa N; Maeda T; Takizawa H; Matsumoto M; Sakai A; Higashiura Y; Gocho Y; Koyama M; Ogawa Y; Miura T
    BMC Nephrol; 2020 Nov; 21(1):459. PubMed ID: 33143633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
    Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
    Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.